RESELIGO

Implant in pre-filled syringe, 3.6mg
RestrictedActive license

Active substance (INN)

goserelin

Pharmaceutical form

Pharmaceutical formImplant in pre-filled syringe
Strength3.6mg
PackagingUkupno 1 implant u napunjenom injekcionom špricu u kartonskoj kutiji
ManufacturerAMW GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L02AE03)
Marketing authorization holderZENTIVA PHARMA DOO - DIO STRANOG DRUŠTVA PODGORICA
Authorization dateNovember 30, 2022

Analogs in Montenegro

3

Other medicines with the same active substance

RESELIGORestricted
Implant in pre-filled syringe, 10.8mgAMW GmbH
ZOLADEXRx
Implant in pre-filled syringe, 3.6mgAstraZeneca UK Limited
ZOLADEX LARx
Implant in pre-filled syringe, 10.8mgAstraZeneca UK Limited
Source: CInMED register